AbbottAt Abbott, we're committed to helping you live your best possible life through the power of health. For more than 125 years, we've brought new products and technologies to the world - in nutrition, diagnostics, medical devices and branded generic pharmaceuticals - that create more possibilities for more people at all stages of life. Today, 73,000 of us are working to help people live not just longer, but better, in the more than 150 countries we serve.

Abbott RSS Channel

Display # 
Title Published Date
Abbott to Acquire Alere, becoming leader in point of care testing 01 February 2016
Abbott and UC San Francisco discover new virus is linked to hepatitis C 14 December 2015
'Science' says Abbott is a Top Employer 30 October 2015
Abbott is asking one million people worldwide. Here's why and how. 22 September 2015
Abbott named industry leader for responsible and sustainable business for three consecutive years on the Dow Jones Sustainability Index (DJSI) 11 September 2015
Abbott completes acquisition of Veropharm 12 December 2014
Abbott to sell its developed markets branded generics pharmaceuticals business to Mylan 14 July 2014
Abbott to acquire Veropharm 23 June 2014
Abbott enhances its position in fast-growing Latin American market 18 May 2014
Abbott reports first-quarter 2014 results 16 April 2014
Abbott completes enrollment of Absorb™ randomized clinical trials in the United States, Japan and China 10 April 2014
Abbott reports fourth-quarter and full-year 2013 results 22 January 2014
Experience a day in the life of an insulin-using patient with diabetes through interactive infographic 14 November 2013
Abbott reports third-quarter 2013 results 16 October 2013
Abbott reports first-quarter 2013 results 17 April 2013
Abbott to collaborate with Janssen and Pharmacyclics 21 February 2013
Abbott initiates clinical trial of Absorb TM in the United States 08 January 2013
Abbott completes separation of research-based pharmaceuticals business 02 January 2013
Abbott announces three-year long-term data evaluating efficacy with HUMIRA® (Adalimumab) 22 October 2012
Abbott reports double digit earnings per share growth in the third quarter 17 October 2012

Digest World Pharma Newsletter

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]